A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2
Clinical trial NCT04384081 · COMPLETED
Trial details
- NCT number
- NCT04384081
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-11-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.